Amira Bisher,PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM). (NCT07020377) | Amira Bisher,PhD | 2024-01-15 |
Track Amira Bisher,PhD automatically
Every clearance here is in the API, with alerts when new ones post.